A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea’s GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday.
Source: Fox News
Got Pests? Call SEE Today 888-287-9805 Pay My Bill
Navigation
- Residential
- Commercial
- Fact Center
- Pests for Kids
- Our Company
- My Account
- Contact
- Search
/* ]]> */